Back to Samsara BioCapital, LLC
Q3 2026 13F filing
Updated 6 days ago27 disclosed positions worth $1.1B
Portfolio value
$1.1B
Total holdings
27
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SCHOLAR ROCK HLDG CORP | $333.3M | 6.90M | 31.69% | — |
| 2 | M MINERALYS THERAPEUTICS INC | $147.5M | 5.87M | 14.03% | — |
| 3 | S SEPTERNA INC | $120M | 3.07M | 11.41% | — |
| 4 | A ALAMAR BIOSCIENCES INC | $84.5M | 2.48M | 8.04% | — |
| 5 | S SPYGLASS PHARMA INC | $54.9M | 2.11M | 5.22% | — |
| 6 | A ALUMIS INC | $53.5M | 7.24M | 5.08% | — |
| 7 | N NEUROGENE INC | $51.9M | 1.87M | 4.94% | — |
| 8 | ? N/A KALARIS THERAPEUTICS INC | $37.2M | 12.88M | 3.54% | — |
| 9 | I INVENTIVA SA | $23.3M | 6.31M | 2.22% | — |
| 10 | P PARABILIS MEDICINES INC | $18M | 556.0K | 1.71% | — |
| 11 | ? N/A SUTRO BIOPHARMA INC | $17.1M | 1.06M | 1.63% | — |
| 12 | P PMV PHARMACEUTICALS INC | $12.1M | 7.24M | 1.15% | — |
| 13 | O OBSIDIAN THERAPEUTICS INC | $11.5M | 837.2K | 1.09% | — |
| 14 | A AQUESTIVE THERAPEUTICS INC | $11.3M | 2.43M | 1.07% | — |
| 15 | V VTV THERAPEUTICS INC | $10.9M | 354.7K | 1.04% | — |
| 16 | J JADE BIOSCIENCES INC | $10.3M | 736.2K | 0.98% | — |
| 17 | N NKARTA INC | $9.2M | 3.51M | 0.87% | — |
| 18 | R RANI THERAPEUTICS HLDGS INC | $8.2M | 10.37M | 0.78% | — |
| 19 | A ARTIVA BIOTHERAPEUTICS INC | $6.8M | 954.9K | 0.65% | — |
| 20 | A AGOMAB THERAPEUTICS NV | $6.6M | 594.7K | 0.63% | — |
| 21 | ? N/A ELOXX PHARMACEUTICALS INC | $6.1M | 400.0K | 0.58% | — |
| 22 | A ABIVAX SA | $5.5M | 55.1K | 0.52% | — |
| 23 | ? N/A COHERUS ONCOLOGY INC | $4.1M | 3.38M | 0.39% | — |
| 24 | ? N/A X4 PHARMACEUTICALS INC | $3.9M | 1.35M | 0.37% | — |
| 25 | ? N/A UPSTREAM BIO INC | $1.6M | 300.4K | 0.15% | — |
| 26 | ? N/A TCGX ACQUISITION CORP | $1.3M | 100.0K | 0.12% | — |
| 27 | G GOSSAMER BIO INC | $1M | 88.0K | 0.10% | — |